Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
CBC
Support for Students with Disabilities
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
Program Resources
You are here
Home
>
Pain
Pain
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.
Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain.
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.
Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain.
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.
Adenosine-A1 receptor agonist induced hyperalgesic priming type II.
Adenosine-A1 receptor agonist induced hyperalgesic priming type II.
Cell transplants to treat the "disease" of neuropathic pain and itch.
Cell transplants to treat the "disease" of neuropathic pain and itch.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »